Jiya in an amended S-1 said it may issue a maximum of 11.5 million shares, which would generate up to $115 million in the offering. The SPAC is focused on biopharmaceutical companies. Read more.
Jiya Amends $100M IPO Prospectus
Related Posts
Ajax I Announces Pricing of $750M IPO, Shares Begin Trading Today
Shares of new SPAC Ajax I began trading today on the NYSE under the ticker symbol “AJAX.U” with a targe raise of $750M.
Clover Leaf Capital Prices $125M IPO
The SPAC is led by President, CEO and Chairman Felipe MacLean, a founder and CEO of Yntegra Group.
HHG Capital Prices $50M IPO
The SPAC has not publicly identified specific sectors it may target for an acquisition, but has excluded targets in China. HHG is based in Singapore.
LightJump Files Definitive Proxy for a Deadline Extension to Complete Work on $504M Moolec Deal
The SPAC two weeks ago announced a definitive merger agreement with UK-based Moolec Sciences.